Current law limits the Minnesota medical cannabis program to two medical cannabis manufacturers. House File 600 or HF600, passed the Minnesota House of Representatives, but not the Minnesota Senate. To legalize recreational use, the bill would need to pass both the House and Senate and be signed by the Governor.
Who Oversees the Medical Marijuana Program?
Currently, the Minnesota Department of Health oversees all aspects of the medical cannabis program in Minnesota. However, the Office of Cannabis Management will begin to oversee the medical cannabis program on March 1, 2025.
The department has registered two medical cannabis manufacturers: Vireo Health of Minnesota and Leafline Labs. Minnesota’s medical cannabis manufacturers are required to grow, process, and distribute medical cannabis to program participants. Minnesota law does not allow registration of additional medical cannabis manufacturers at this time.
Minnesota Medical Cannabis Sale Restrictions
Patient allotments can vary based on doctors recommendations. It is also important to note that dried flower may only be purchased by Minnesota medical cannabis patients whom are over the age of 21. These limitations are outlined in our Minnesota Dispensary Standard Operating Procedures.
